Patent family “Isolation of Stem/Progenitor Cells from Amniotic Membrane of Umbilical Cord”
Europe (17 Territories) Patent
United Kingdom Patent
New Zealand Patent
South Africa Patent
Hong Kong Patent
Patent family “Isolation and Cultivation of Stem/Progenitor Cells from the Amniotic Membrane of Umbilical Cord and uses of Cells Differentiated Therefrom”
Make an informed choice. Select a cord banking service that is licensed to offer complete coverage for all stem cell therapies derived from your stored cord.
Umbilical cord lining tissue banked by non-licensed cord blood banks may not provide the stem cell yield or quality that CellResearch Corporation’s proprietary and patented protocols can provide — this may affect its suitability for future therapeutic use. In addition, these blood banks and medical institutions that offer CellResearch Corporation's patented protocols — which include ALL cord lining stem cell therapies — are at risk of patent infringement.
GlobalCord is operated bv CellResearch Corporation and its partners. Cords banked through GlobalCord are covered by CellResearch Corporation’s patent licensure